Anavex Life Sciences (AVXL) Tax Rate Growth (3y) (2019 - 2025)

Anavex Life Sciences (AVXL) Tax Rate Growth (3y) (2019 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn
7 Belite Bio 62.72 Bn 62.72 Bn -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn -
10 Anavex Life Sciences 223.91 Mn 92.16 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 -15.00
Jun 30, 2024 93.00
Mar 31, 2024 -67.00
Dec 31, 2023 -24.00
Sep 30, 2023 77.00
Jun 30, 2023 -29.00
Dec 31, 2022 29.00
Sep 30, 2022 -138.00
Jun 30, 2022 -42.00
Mar 31, 2022 38.00
Dec 31, 2021 -15.00
Sep 30, 2021 -61.00
Mar 31, 2021 26.00
Dec 31, 2020 -53.00
Sep 30, 2020 3.00
Jun 30, 2020 20.00
Dec 31, 2019 86.00
Sep 30, 2019 -2.00
Jun 30, 2019 -3.00